AKT1 and breast cancer: Both glycated-HDL and ox-HDL show a higher ability to promote cell proliferation and migration of breast cancer cells involving different pathways (Akt, ERK, and mitogen-activated protein kinase (MAPK) compared with control HDL [123, 127].